Salim Dhanji
Amministratore Delegato presso ME THERAPEUTICS HOLDINGS INC.
Patrimonio netto: 20 M $ in data 30/04/2024
Posizioni attive di Salim Dhanji
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ME THERAPEUTICS HOLDINGS INC. | Direttore/Membro del Consiglio | 09/03/2023 | - |
| Amministratore Delegato | 09/03/2023 | - |
Storia della carriera di Salim Dhanji
Precedenti posizioni note di Salim Dhanji
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Qu Biologics, Inc.
 Qu Biologics, Inc. BiotechnologyHealth Technology Qu Biologics, Inc. develops site specific immunomodulators that aim to restore the body's innate immune system to treat cancer. The firm specializes in ulcerative colitis, Crohn's disease, arthritis, cancer, autoimmune diseases, autoimmune disorders, inflammatory bowel disease, IBD, Site Specific Immunomodulators, immunotherapies, investigational drug, auto-immune, pharmaceuticals, research, inflammation, biotech and clinical trials. The company was founded by Harold David Gunn and Rob Freeman in 2007 and is headquartered in Burnaby, Canada. | Corporate Officer/Principal | 01/01/2009 | 01/01/2014 |
Formazione di Salim Dhanji
| University of British Columbia | Doctorate Degree |
Statistiche
Distribuzione geografica
| Canada | 4 |
Posizioni
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
| Doctorate Degree | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ME THERAPEUTICS HOLDINGS INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Qu Biologics, Inc.
Qu Biologics, Inc. BiotechnologyHealth Technology Qu Biologics, Inc. develops site specific immunomodulators that aim to restore the body's innate immune system to treat cancer. The firm specializes in ulcerative colitis, Crohn's disease, arthritis, cancer, autoimmune diseases, autoimmune disorders, inflammatory bowel disease, IBD, Site Specific Immunomodulators, immunotherapies, investigational drug, auto-immune, pharmaceuticals, research, inflammation, biotech and clinical trials. The company was founded by Harold David Gunn and Rob Freeman in 2007 and is headquartered in Burnaby, Canada. | Health Technology |
- Borsa valori
- Insiders
- Salim Dhanji
- Esperienza